|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-2-3
|
|
pubmed:abstractText |
Currently, clinical trials using WT1 (Wilms tumour gene) peptide vaccines are conducted in haematopoietic malignancies and solid cancers. Single reports showed that the Wilms tumour gene product WT1 is also expressed in astrocytic neoplasms. Our aim was to investigate WT1 expression in a large cohort of various neuroepithelial tumours of different World Health Organization (WHO) grades and in normal central nervous system (CNS) tissue specimens to test its potential value as a diagnostic marker.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1365-2990
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
69-81
|
|
pubmed:meshHeading |
pubmed-meshheading:18466223-Adult,
pubmed-meshheading:18466223-Blotting, Western,
pubmed-meshheading:18466223-Brain,
pubmed-meshheading:18466223-Brain Neoplasms,
pubmed-meshheading:18466223-Child,
pubmed-meshheading:18466223-Endothelial Cells,
pubmed-meshheading:18466223-Female,
pubmed-meshheading:18466223-Humans,
pubmed-meshheading:18466223-Immunohistochemistry,
pubmed-meshheading:18466223-Logistic Models,
pubmed-meshheading:18466223-Male,
pubmed-meshheading:18466223-Middle Aged,
pubmed-meshheading:18466223-Neoplasms, Neuroepithelial,
pubmed-meshheading:18466223-RNA, Messenger,
pubmed-meshheading:18466223-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18466223-Tissue Array Analysis,
pubmed-meshheading:18466223-WT1 Proteins,
pubmed-meshheading:18466223-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Diagnostic value of WT1 in neuroepithelial tumours.
|
|
pubmed:affiliation |
Institute of Brain Research, University of Tuebingen, Tuebingen, Germany.
|
|
pubmed:publicationType |
Journal Article
|
